Care Institute Of Rheumatology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -18.73%
(FY 2022)
- Profit -30.17%
(FY 2022)
- Ebitda 3.80%
(FY 2022)
- Net Worth 3.42%
(FY 2022)
- Total Assets 3.83%
(FY 2022)
About Care Institute Of Rheumatology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Aggarwal and Sachin Aggarwal serve as directors at the Company.
- CIN/LLPIN
U93000DL2013PTC249176
- Company No.
249176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2013
- Date of AGM
09 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Care Institute Of Rheumatology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Aggarwal  | Director | 06-Mar-2013 | Current |
| Sachin Aggarwal | Director | 12-Dec-2023 | Current |
Financial Performance of Care Institute Of Rheumatology.
Care Institute Of Rheumatology Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 18.73% decrease. The company also saw a substantial fall in profitability, with a 30.17% decrease in profit. The company's net worth moved up by a moderate rise of 3.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Care Institute Of Rheumatology?
In 2022, Care Institute Of Rheumatology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
W360 Sophisticated Solutions Private LimitedActive 5 years 8 monthsSachin Aggarwal is a mutual person
Australian Retail College (India) Private LimitedActive 11 years 10 monthsRahul Aggarwal is a mutual person
Inaya Trading Private LimitedActive 7 years 11 monthsRahul Aggarwal and Sachin Aggarwal are mutual person
- Nivit Techworld India Private LimitedActive 7 years 11 months
Rahul Aggarwal and Sachin Aggarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Care Institute Of Rheumatology?
Unlock and access historical data on people associated with Care Institute Of Rheumatology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Care Institute Of Rheumatology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Care Institute Of Rheumatology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
